| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.4 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |